Navigation Links
Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA
Date:9/1/2010

Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA -- CASTRES, France, September 1, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA

 

CASTRES, France, September 1, 2010 /PRNewswire/ -- During its first meeting, the Board of Directors of Pierre Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive vice-president of Abbott Corporation and president of its pharmaceutics division. In this capacity, he directed the group's entire pharmaceutical business (22 billion dollars turnover) from Chicago. He also became group president for Europe in 2003 and subsequently president of Abbott international.

Olivier BOHUON has also been appointed president of Pierre Fabre Medicament as of today.

About the Pierre Fabre group

The Pierre Fabre group, owned on a majority basis by a public utility Foundation, is France's second largest independent pharmaceutics laboratory and the leader in cosmetics products sold in pharmacies.

It employs a workforce of nearly 10,000 including 1,400 in research.

In 2009, the Pierre Fabre group achieved a turnover of 1.8 billion EUR and dedicated 28% of its medical turnover to research and development in three main therapeutic areas: oncology, central nervous system, dermatology and cardio-vascular/metabolism.

To find out more about Laboratoires Pierre Fabre : http://www.pierre-fabre.com


'/>"/>
SOURCE Groupe Pierre Fabre
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Olivier Bohuon Joins Pierre Fabre
2. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
3. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
4. Robert Cantu Appointed Vice President of Pierpoint International
5. Timothy I. Still Appointed CEO at Accumetrics
6. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
7. Paul Keim Appointed to febits Scientific Advisory Board
8. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
9. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
10. FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout
11. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):